Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 30 of 78 for:    vismodegib

Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02337517
Recruitment Status : Terminated
First Posted : January 13, 2015
Last Update Posted : February 8, 2019
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 31, 2018
Actual Study Completion Date : December 31, 2018